StoryFunding
NewLimit raises $130M Series B led by Kleiner Perkins
NewLimit raised $130M in a Series B led by Kleiner Perkins, with new investors including Nat Friedman and Daniel Gross, Khosla Ventures, and Human Capital, alongside existing backers Dimension, Founders Fund, and Brian Armstrong. Notable angel investors included the Collison brothers and other notable technologists.
- $130M Series B led by Kleiner Perkins; new investors include NFDG, Khosla Ventures, Human Capital, and Valor Equity Partners.
- Existing investors Dimension, Founders Fund, and Brian Armstrong participated; notable angels include John and Patrick Collison.
- Capital supports development of medicines using epigenetic reprogramming technology combined with AI-driven drug discovery.